Wahl RL - Search Results

1

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Wahl RL, Jacene H, Kasamon Y, Lodge MA. Wahl RL, et al. J Nucl Med. 2009 May;50 Suppl 1(Suppl 1):122S-50S. doi: 10.2967/jnumed.108.057307. J Nucl Med. 2009. PMID: 19403881 Free PMC article. Review.

2

"Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity.

Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. Wahl RL, et al. J Nucl Med. 1993 Jul;34(7):1190-7. J Nucl Med. 1993. PMID: 8315501 Free article.

3

Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results.

Sugawara Y, Braun DK, Kison PV, Russo JE, Zasadny KR, Wahl RL. Sugawara Y, et al. Among authors: wahl rl. Eur J Nucl Med. 1998 Sep;25(9):1238-43. doi: 10.1007/s002590050290. Eur J Nucl Med. 1998. PMID: 9724371 Free article.

4

Evaluation of FDG PET in patients with cervical cancer.

Sugawara Y, Eisbruch A, Kosuda S, Recker BE, Kison PV, Wahl RL. Sugawara Y, et al. Among authors: wahl rl. J Nucl Med. 1999 Jul;40(7):1125-31. J Nucl Med. 1999. PMID: 10405131 Free article.

5

Metabolic response of non-Hodgkin's lymphoma to 131I-anti-B1 radioimmunotherapy: evaluation with FDG PET.

Torizuka T, Zasadny KR, Kison PV, Rommelfanger SG, Kaminski MS, Wahl RL. Torizuka T, et al. Among authors: wahl rl. J Nucl Med. 2000 Jun;41(6):999-1005. J Nucl Med. 2000. PMID: 10855624 Free article.

6

Current status of PET in breast cancer imaging, staging, and therapy.

Wahl RL. Wahl RL. Semin Roentgenol. 2001 Jul;36(3):250-60. doi: 10.1053/sroe.2001.25126. Semin Roentgenol. 2001. PMID: 11475071 Review.

7

Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy.

Nakamoto Y, Eisbruch A, Achtyes ED, Sugawara Y, Reynolds KR, Johnston CM, Wahl RL. Nakamoto Y, et al. Among authors: wahl rl. Gynecol Oncol. 2002 Feb;84(2):289-95. doi: 10.1006/gyno.2001.6504. Gynecol Oncol. 2002. PMID: 11812089 Clinical Trial.

8

PET scanning and measuring the impact of treatment.

Cohade C, Wahl RL. Cohade C, et al. Among authors: wahl rl. Cancer J. 2002 Mar-Apr;8(2):119-34. doi: 10.1097/00130404-200203000-00006. Cancer J. 2002. PMID: 11999946 Review.

9

PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images.

Nakamoto Y, Osman M, Cohade C, Marshall LT, Links JM, Kohlmyer S, Wahl RL. Nakamoto Y, et al. Among authors: wahl rl. J Nucl Med. 2002 Sep;43(9):1137-43. J Nucl Med. 2002. PMID: 12215550 Free article.

10

Comparison of mutual information-based warping accuracy for fusing body CT and PET by 2 methods: CT mapped onto PET emission scan versus CT mapped onto PET transmission scan.

Skalski J, Wahl RL, Meyer CR. Skalski J, et al. Among authors: wahl rl. J Nucl Med. 2002 Sep;43(9):1184-7. J Nucl Med. 2002. PMID: 12215557 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

612 results

Search Page

Filters